Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system

Arthritis and Rheumatism

Volumn 58, Issue 10, 2008, Pages 3110-3119

  Inglis, Julia J ^a   McNamee, Kay E ^a   Chia, Shi Lu ^a   Essex, David ^a   Feldmann, Marc ^a   Williams, Richard O ^a   Hunt, Stephen P ^b   Vincent, Tonia ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALOXONE; CELECOXIB; HYDROXYPROPYLMETHYLCELLULOSE; MORPHINE SULFATE; NALOXONE; OPIATE; OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRALGIA; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; JOINT INJURY; LIGAMENT INJURY; MALE; MOUSE; MUSCLE INNERVATION; NOCICEPTION; NONHUMAN; OSTEOARTHRITIS; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STUDENT T TEST; TREATMENT RESPONSE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CARTILAGE; MALE; MICE; OPIOID PEPTIDES; OSTEOARTHRITIS, KNEE; PAIN; RECEPTORS, OPIOID, MU;

EID: 54949120174     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23870     Document Type: Article

References (33)

1. Zatarain E, Strand V. Monitoring disease activity of rheumatoid arthritis in clinical practice: contributions from clinical trials [review]. Nat Clin Pract Rheumatol 2006;211:611-8.
2. Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer pain [review]. Nat Rev Cancer 2002;23:201-9.
3. Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA. Osteoarthritis: an untreatable disease? [review] [published erratum appears in Nat Rev Drug Discov 2005;4:543]. Nat Rev Drug Discov 2005;4:331-44.
4. Kidd BL. Osteoarthritis and joint pain [review]. Pain 2006;123:6-9.
5. Ameye LG, Young MF. Animal models of osteoarthritis: lessons learned while seeking the "Holy Grail" [review]. Curr Opin Rheumatol 2006;18:537-47.
6. Rudolphi K, Gerwin N, Verzijl N, van der Kraan P, van den Berg W. Pralnacasan, an inhibitor of interleukin-1β converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis Cartilage 2003;11:738-46.
7. Pritzker KP. Animal models for osteoarthritis: processes, problems and prospects [review]. Ann Rheum Dis 1994;53:406-20.
8. Ivanavicius SP, Ball AD, Heapy CG, Westwood FR, Murray F, Read SJ. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation. Pain 2007;128:272-82.
9. Glasson SS, Askew R, Sheppard B, Carito BA, Blanchet T, Ma HL, et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum 2004;50:2547-58.
10. Ma HL, Blanchet TJ, Peluso D, Hopkins B, Morris EA, Glasson SS. Osteoarthritis severity is sex dependent in a surgical mouse model. Osteoarthritis Cartilage 2007;15:695-700.
11. Chambers MG, Bayliss MT, Mason RM. Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis Cartilage 1997;5:301-8.
12. Barton NJ, McQueen DS, Thomson D, Gauldie SD, Wilson AW, Salter DM, et al. Attenuation of experimental arthritis in TRPV1R knockout mice. Exp Mol Pathol 2006;81:166-70.
13. Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, et al. Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 2004;112:83-93.
14. Inglis JJ, Notley CA, Essex D, Wilson AW, Feldmann M, Anand P, et al. Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum 2007;56:4015-23.
15. Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, et al. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 2005;114:339-46.
16. Quinn LP, Stean TO, Chapman H, Brown M, Vidgeon-Hart M, Upton N, et al. Further validation of LABORAS using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degeneration. J Neurosci Methods 2006;156:218-27.
17. Van de Weerd HA, Bulthuis RJ, Bergman AF, Schlingmann F, Tolboom J, Van Loo PL, et al. Validation of a new system for the automatic registration of behaviour in mice and rats. Behav Processes 2001;53:11-20.
18. Shu SY, Ju G, Fan LZ. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 1988;85:169-71.
19. Williams RO. Models of rheumatoid arthritis. Ernst Schering Res Found Workshop 2005;50:89-117.
20. Williams RO, Inglis JJ, Simelyte E, Criado G, Sumariwalla PF. Analysing the effect of novel therapies on cytokine expression in experimental arthritis [review]. Int J Exp Pathol 2005;86:267-78.
21. Clemett D, Goa KL. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain [published erratum appears in Drugs 2001;61:498]. Drugs 2000;59:957-80.
22. Cirulli F, De Acetis L, Alleva E. Behavioral effects of peripheral interleukin-1 administration in adult CD-1 mice: specific inhibition of the offensive components of intermale agonistic behavior. Brain Res 1998;791:308-12.
23. Puehler W, Zollner C, Brack A, Shaqura MA, Krause H, Schafer M, et al. Rapid upregulation of μ opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience 2004;129:473-9.
24. Sevcik MA, Jonas BM, Lindsay TH, Halvorson KG, Ghilardi JR, Kuskowski MA, et al. Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer. Gastroenterology 2006;131:900-10.
25. Kraus J, Borner C, Giannini E, Hollt V. The role of nuclear factor κB in tumor necrosis factor-regulated transcription of the human μ-opioid receptor gene. Mol Pharmacol 2003;64:876-84.
26. Vidal EL, Patel NA, Wu G, Fiala M, Chang SL. Interleukin-1 induces the expression of μ opioid receptors in endothelial cells. Immunopharmacology 1998;38:261-6.
27. Kohno T, Ji RR, Ito N, Allchorne AJ, Befort K, Karchewski LA, et al. Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord. Pain 2005;117:77-87.
28. Bergstrom J, Ahmed M, Li J, Ahmad T, Kreicbergs A, Spetea M. Opioid peptides and receptors in joint tissues: study in the rat. J Orthop Res 2006;24:1193-9.
29. Bender T, Barna I, Geher P. Synovial immunoreactive β-endorphin levels in rheumatoid arthritis and osteoarthritis [letter]. Clin Exp Rheumatol 1999;17:630.
30. Likar R, Schafer M, Paulak F, Sittl R, Pipam W, Schalk H, et al. Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth Analg 1997;84:1313-7.
31. Le Loet X, Pavelka K, Richarz U. Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre study. BMC Musculoskelet Disord 2005;6:31.
32. Stein C. Peripheral mechanisms of opioid analgesia [review]. Anesth Analg 1993;76:182-91.
33. Stein A, Yassouridis A, Szopko C, Helmke K, Stein C. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999;83:525-32.